Figure 1 Routine 6-month evaluation of hypertension patients who were enrolled in the Indonesian Chronic Disease Management Program (PROLANIS)Data are displayed as mean±SD for normally distributed data (TC, LDL, and eGFR) and displayed as median [IQR] for skewed data (BMI, SBP, DBP, TG, and HDL). BMI – body mass index; DBP – diastolic blood pressure; eGFR – estimated glomerular filtration rate calculated using CKD-EPI equation; HDL – high-density lipid; LDL – low-density lipid; SBP – systolic blood pressure; TC – total cholesterol; TG – triglyceride. T0 – evaluation in December 2019 (before the COVID-19 pandemic); T1 – evaluation in June 2020 (during the COVID-19 pandemic); T2 – evaluation in December 2020 (during the COVID-19 pandemic). The paired t test was used for normally distributed data and non-parametric Wilcoxon signed-rank test was used for skewed data. * P value <0.05 was considered statistically significant.